Insights into the mode of action of chitosan as an antibacterial compound D Raafat, K Von Bargen, A Haas, HG Sahl Applied and environmental microbiology 74 (12), 3764-3773, 2008 | 1075 | 2008 |
Chitosan and its antimicrobial potential–a critical literature survey D Raafat, HG Sahl Microbial biotechnology 2 (2), 186-201, 2009 | 957 | 2009 |
Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries SR Knight, CA Shaw, R Pius, TM Drake, L Norman, AO Ademuyiwa, ... The Lancet 397 (10272), 387-397, 2021 | 114 | 2021 |
Green synthesis of silver nanoparticles using cranberry powder aqueous extract: characterization and antimicrobial properties AA Ashour, D Raafat, HM El-Gowelli, AH El-Kamel International Journal of Nanomedicine, 7207-7221, 2015 | 86 | 2015 |
Fighting Staphylococcus aureus biofilms with monoclonal antibodies D Raafat, M Otto, K Reppschläger, J Iqbal, S Holtfreter Trends in microbiology 27 (4), 303-322, 2019 | 81 | 2019 |
Phenotypic and genotypic detection of metallo-beta-lactamases in imipenem-resistant Acinetobacter baumannii isolated from a tertiary hospital in Alexandria, Egypt NM Mohamed, D Raafat Research Journal of Microbiology 6 (10), 750, 2011 | 38 | 2011 |
Development of in vitro resistance to chitosan is related to changes in cell envelope structure of Staphylococcus aureus D Raafat, N Leib, M Wilmes, P François, J Schrenzel, HG Sahl Carbohydrate polymers 157, 146-155, 2017 | 34 | 2017 |
Staphylococcus aureus Host Tropism and Its Implications for Murine Infection Models DM Mrochen, LM Fernandes de Oliveira, D Raafat, S Holtfreter International journal of molecular sciences 21 (19), 7061, 2020 | 29 | 2020 |
Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia J Vlaeminck, D Raafat, K Surmann, L Timbermont, N Normann, B Sellman, ... Toxins 12 (11), 721, 2020 | 24 | 2020 |
Chitosan as an antimicrobial compound: modes of action and resistance mechanisms DRG Fouad Bonn, Univ., Diss., 2008, 2008 | 22 | 2008 |
Molecular epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in wild, captive and laboratory rats: Effect of habitat on the nasal S. aureus … D Raafat, DM Mrochen, F Al’Sholui, E Heuser, R Ryll, ... Toxins 12 (2), 80, 2020 | 21 | 2020 |
Chitosan and its antimicrobial potential–a critical literature survey. Microb Biotechnol 2: 186–201 D Raafat, HG Sahl | 21 | 2009 |
Microbiological testing of pharmaceuticals and cosmetics in Egypt H Zeitoun, M Kassem, D Raafat, H AbouShlieb, N Fanaki BMC microbiology 15, 1-13, 2015 | 20 | 2015 |
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study SR Knight, CA Shaw, R Pius, TM Drake, L Norman, AO Ademuyiwa, ... The Lancet global health 10 (7), e1003-e1011, 2022 | 15 | 2022 |
Anti-neuronal antibodies against brainstem antigens are associated with COVID-19 G Lucchese, A Vogelgesang, F Boesl, D Raafat, S Holtfreter, BM Bröker, ... EBioMedicine 83, 2022 | 13 | 2022 |
Antibody production in murine polymicrobial Sepsis—kinetics and key players O Nicolai, C Pötschke, K Schmoeckel, MN Darisipudi, J Van der Linde, ... Frontiers in immunology 11, 828, 2020 | 12 | 2020 |
Pet rats as the likely reservoir for human Seoul orthohantavirus infection E Heuser, S Drewes, J Trimpert, D Kunec, C Mehl, MP de Cock, ... Viruses 15 (2), 467, 2023 | 7 | 2023 |
Tertiary Hospital in Alexandria, Egypt NM Mohamed, D Raafat Research Journal of Microbiology 6 (10), 750-730, 2011 | 4 | 2011 |
Pathogen-specific antibody profiles in patients with severe systemic infections N Normann, G Tietz, AW Kühn, C Fuchs, V Balau, K Schulz, J Kolata, ... Eur Cells & Mater. 39, 171-182, 2020 | 3 | 2020 |
The 2023 Orthopaedic Research Society's International Consensus Meeting on musculoskeletal infection: Summary from the host immunity section EM Schwarz, NK Archer, GJ Atkins, KLM Bentley, M Botros, JE Cassat, ... Journal of Orthopaedic Research® 42 (3), 518-530, 2024 | 2 | 2024 |